MUSCULAR DISORDERS, ATROPHIC
Clinical trials for MUSCULAR DISORDERS, ATROPHIC explained in plain language.
Never miss a new study
Get alerted when new MUSCULAR DISORDERS, ATROPHIC trials appear
Sign up with your email to follow new studies for MUSCULAR DISORDERS, ATROPHIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for boys with rare form of muscular dystrophy
Disease control CompletedThis study tested a drug called ataluren in 360 boys (age 5 and older) with Duchenne muscular dystrophy caused by a specific genetic mistake called a nonsense mutation. The goal was to see if ataluren could help them walk farther over 72 weeks compared to a placebo. All participa…
Matched conditions: MUSCULAR DISORDERS, ATROPHIC
Phase: PHASE3 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Experimental DM1 drug shows promise in long-term safety trial
Disease control CompletedThis study looked at the long-term safety of a drug called AOC 1001 in adults with myotonic dystrophy type 1 (DM1), a genetic muscle disease. 37 people who completed an earlier study received multiple doses of the drug by IV. Researchers tracked side effects and measured drug lev…
Matched conditions: MUSCULAR DISORDERS, ATROPHIC
Phase: PHASE2 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated May 07, 2026 18:42 UTC